Federal Government Guidelines Recommend Chantix For Quit Smoking
Date: 8th May 2008
According to a latest revelation, the federal government in the US has asked doctors to recommend the Pfizer manufactured anti-smoking pill chantix to smokers who are eager to quit smoking. The guidelines released by the government mention the psychiatric risks such as depression and suicidal behavior that are likely to occur on account of chantix usage and stresses on the importance of counseling for quick relief from smoking addiction.
These smoking cessation guidelines are released by the U.S. Public Health Service and Dr. Michael Fiore, a specialist on quit smoking and other health related issues is the leading author of these guidelines. The guidelines are reportedly reviewed by 90 health experts and supported by 60 public health entities. Altogether, it is known that the guidelines have instructed the doctors to inquire into a patient's psychiatric history before providing chantix prescription and have also asked them to carefully consider the mood and behavior changes of patients using chantix.
Before preparing the quit smoking guidelines, the authors conducted 83 studies which led to the conclusion that 33 percent smokers using the anti-smoking medication chantix were able to abstain from smoking for six months while only 14 percent using dummy pills were able to give up smoking addiction. In these experiments, Chantix, the smoking cessation medicine has not been found effective on certain groups of people, namely, adolescents, pregnant women, light smokers, smokeless tobacco users etc and therefore the guidelines state that counseling and medicines are equally necessary to trigger off quit smoking.